Topic
11 articles from the Ganjette archive.
The U.S. federal cannabis conversation is entering a new phase as authorities move certain cannabis-related substances and medical systems toward Schedule III treatment. This is a major shift, but not nationwide adult-use legalization and not the end of every ...
Read article →
Thailand’s cannabis industry is now operating under much tighter expectations than during the boom period. Advertising, recreational sales, prescriptions, certified cultivation, and clinic-style operations are becoming the core issues. Shops that once depended...
Read article →
The cannabis industry closes 2025 with a split identity. Medical cannabis continues gaining institutional seriousness, while recreational access faces political resistance in some markets and careful control in others. Germany is still shaping its model, Thail...
Read article →
Thailand’s cannabis sector is being forced to define what kind of industry it wants to be. The open retail energy that made the country famous is colliding with a medical-first regulatory push. Clinics, patient records, certified farms, compliant sourcing, sta...
Read article →
Thailand’s cannabis industry is moving into a more restrictive phase as authorities push the market back toward medical use and tighter controls. Operators are not yet dead, but the easy-open period is clearly under pressure. Medical certificates, flower sales...
Read article →
While adult-use reform moves slowly, medical cannabis services are becoming more visible across Europe. Patients are searching for access, doctors are learning where cannabis fits, pharmacies are handling specialized products, and digital healthcare providers ...
Read article →
Europe’s cannabis shift is quieter than activists once imagined and slower than investors prefer, but it is real. Medical access, pilot programs, decriminalization debates, German legalization, and national-level experiments are creating a gradual normalizatio...
Read article →
Germany’s adult-use reform is changing the public conversation, but medical cannabis remains its own serious healthcare lane. Patients, doctors, pharmacies, telemedicine providers, and importers are adjusting to a market where cannabis is more normalized but s...
Read article →
The cannabis industry is ending 2023 in a more serious mood. Easy capital is harder to find, regulation is slower than many expected, and operators are being forced to prove that they can survive beyond headlines. Germany is still preparing reform, Thailand is...
Read article →
While adult-use legalization attracts headlines, medical cannabis remains the more realistic commercial lane across much of Europe. It fits existing healthcare systems better than open retail, it can be regulated through prescriptions and pharmacies, and it gi...
Read article →
Thailand’s cannabis scene is exploding in public view, especially in tourist areas, but the rules are still catching up with the reality on the street. Dispensaries, cafés, wellness concepts, growers, and foreign entrepreneurs are moving fast while officials d...
Read article →
Newsletter
Join operators, investors and policy readers who use Ganjette as a calm, serious cannabis market desk.